353 related articles for article (PubMed ID: 27847146)
1. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
[TBL] [Abstract][Full Text] [Related]
2. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
[TBL] [Abstract][Full Text] [Related]
3. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
4. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
[TBL] [Abstract][Full Text] [Related]
5. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
7. Skin autofluorescence is associated with vascular complications in patients with type 2 diabetes.
Osawa S; Katakami N; Sato I; Ninomiya H; Omori K; Yamamoto Y; Takahara M; Miyashita K; Sakamoto F; Kawamori D; Matsuoka T; Shimomura I
J Diabetes Complications; 2018 Sep; 32(9):839-844. PubMed ID: 30099985
[TBL] [Abstract][Full Text] [Related]
8. Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes.
Ninomiya H; Katakami N; Sato I; Osawa S; Yamamoto Y; Takahara M; Kawamori D; Matsuoka TA; Shimomura I
J Atheroscler Thromb; 2018 Dec; 25(12):1274-1284. PubMed ID: 29962379
[TBL] [Abstract][Full Text] [Related]
9. Skin autofluorescence associates with vascular calcification in chronic kidney disease.
Wang AY; Wong CK; Yau YY; Wong S; Chan IH; Lam CW
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1784-90. PubMed ID: 24876353
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
11. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes.
Meerwaldt R; Lutgers HL; Links TP; Graaff R; Baynes JW; Gans RO; Smit AJ
Diabetes Care; 2007 Jan; 30(1):107-12. PubMed ID: 17192342
[TBL] [Abstract][Full Text] [Related]
12. Peyronie's disease in diabetic patients being screened for erectile dysfunction.
El-Sakka AI; Tayeb KA
J Urol; 2005 Sep; 174(3):1026-30. PubMed ID: 16094040
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and correlates of erectile dysfunction in type 2 diabetes mellitus: a cross-sectional single-center study among Turkish patients.
Cander S; Coban S; Altuner S; Oz Gul O; Yetgin ZA; Akkurt A; Ucar H; Tuncel E
Metab Syndr Relat Disord; 2014 Aug; 12(6):324-9. PubMed ID: 24666397
[TBL] [Abstract][Full Text] [Related]
14. Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients.
Hirano T; Iesato Y; Toriyama Y; Imai A; Chiba D; Murata T
J Diabetes Complications; 2014; 28(5):729-34. PubMed ID: 24795072
[TBL] [Abstract][Full Text] [Related]
15. Within- and Between-Body-Site Agreement of Skin Autofluorescence Measurements in People With and Without Diabetes-Related Foot Disease.
Fernando ME; Crowther RG; Lazzarini PA; Sangla KS; Wearing S; Buttner P; Golledge J
J Diabetes Sci Technol; 2019 Sep; 13(5):836-846. PubMed ID: 31204497
[TBL] [Abstract][Full Text] [Related]
16. The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation.
van Waateringe RP; Mook-Kanamori MJ; Slagter SN; van der Klauw MM; van Vliet-Ostaptchouk JV; Graaff R; Lutgers HL; Suhre K; El-Din Selim MM; Mook-Kanamori DO; Wolffenbuttel BHR
PLoS One; 2017; 12(6):e0179330. PubMed ID: 28632785
[TBL] [Abstract][Full Text] [Related]
17. [Erectile dysfunction and diabetes in Conakry (Guinea): frequency and clinical characteristics from 187 diabetic patients].
Baldé NM; Diallo AB; Baldé MC; Kaké A; Diallo MM; Diallo MB; Maugendre D
Ann Endocrinol (Paris); 2006 Sep; 67(4):338-42. PubMed ID: 17072239
[TBL] [Abstract][Full Text] [Related]
18. A community-based study on prevalence and correlates of erectile dysfunction among Kinondoni District Residents, Dar Es Salaam, Tanzania.
Pallangyo P; Nicholaus P; Kisenge P; Mayala H; Swai N; Janabi M
Reprod Health; 2016 Nov; 13(1):140. PubMed ID: 27899129
[TBL] [Abstract][Full Text] [Related]
19. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.
Lutgers HL; Graaff R; Links TP; Ubink-Veltmaat LJ; Bilo HJ; Gans RO; Smit AJ
Diabetes Care; 2006 Dec; 29(12):2654-9. PubMed ID: 17130200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
